Canada Life’s Blueprint Medicines BPMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-14,186
| Closed | -$1.82M | – | 1921 |
|
|
2025
Q2 | $1.82M | Buy |
14,186
+6,565
| +86% | +$682K | ﹤0.01% | 1228 |
|
|
2025
Q1 | $676K | Buy |
7,621
+1,401
| +23% | +$137K | ﹤0.01% | 1541 |
|
|
2024
Q4 | $541K | Sell |
6,220
-1,345
| -18% | -$123K | ﹤0.01% | 1626 |
|
|
2024
Q3 | $700K | Buy |
7,565
+292
| +4% | +$29K | ﹤0.01% | 1607 |
|
|
2024
Q2 | $785K | Buy |
7,273
+439
| +6% | +$43.9K | ﹤0.01% | 1563 |
|
|
2024
Q1 | $648K | Buy |
6,834
+256
| +4% | +$22K | ﹤0.01% | 1623 |
|
|
2023
Q4 | $603K | Sell |
6,578
-13,131
| -67% | -$851K | ﹤0.01% | 1657 |
|
|
2023
Q3 | $988K | Buy |
19,709
+3,854
| +24% | +$206K | ﹤0.01% | 1480 |
|
|
2023
Q2 | $1.01M | Buy |
15,855
+1,093
| +7% | +$59.4K | ﹤0.01% | 1490 |
|
|
2023
Q1 | $665K | Buy |
14,762
+3
| +0% | +$135 | ﹤0.01% | 1621 |
|
|
2022
Q4 | $650K | Buy |
14,759
+5,521
| +60% | +$265K | ﹤0.01% | 1652 |
|
|
2022
Q3 | $608K | Buy |
9,238
+6,169
| +201% | +$396K | ﹤0.01% | 1646 |
|
|
2022
Q2 | $155K | Buy |
3,069
+93
| +3% | +$5.45K | ﹤0.01% | 1854 |
|
|
2022
Q1 | $202K | Sell |
2,976
-166
| -5% | -$11.9K | ﹤0.01% | 1869 |
|
|
2021
Q4 | $335K | Buy |
3,142
+87
| +3% | +$9.1K | ﹤0.01% | 1788 |
|
|
2021
Q3 | $316K | Hold |
3,055
| – | – | ﹤0.01% | 1814 |
|
|
2021
Q2 | $269K | Sell |
3,055
-267
| -8% | -$24.5K | ﹤0.01% | 1865 |
|
|
2021
Q1 | $321K | Sell |
3,322
-432
| -12% | -$43.1K | ﹤0.01% | 1838 |
|
|
2020
Q4 | $420K | Buy |
3,754
+459
| +14% | +$48.4K | ﹤0.01% | 1793 |
|
|
2020
Q3 | $306K | Hold |
3,295
| – | – | ﹤0.01% | 1796 |
|
|
2020
Q2 | $255K | Hold |
3,295
| – | – | ﹤0.01% | 1850 |
|
|
2020
Q1 | $194K | Hold |
3,295
| – | – | ﹤0.01% | 1819 |
|
|
2019
Q4 | $262K | Buy |
3,295
+286
| +10% | +$21.4K | ﹤0.01% | 1867 |
|
|
2019
Q3 | $221K | Sell |
3,009
-2,133
| -41% | -$184K | ﹤0.01% | 973 |
|
|
2019
Q2 | $484K | Sell |
5,142
-797
| -13% | -$65.8K | ﹤0.01% | 1779 |
|
|
2019
Q1 | $474K | Buy |
5,939
+1,002
| +20% | +$74K | ﹤0.01% | 1644 |
|
|
2018
Q4 | $257K | Hold |
4,937
| – | – | ﹤0.01% | 1868 |
|
|
2018
Q3 | $385K | Hold |
4,937
| – | – | ﹤0.01% | 1811 |
|
|
2018
Q2 | $313K | Hold |
4,937
| – | – | ﹤0.01% | 1853 |
|
|
2018
Q1 | $453K | Buy |
4,937
+1,605
| +48% | +$138K | ﹤0.01% | 1759 |
|
|
2017
Q4 | $251K | Hold |
3,332
| – | – | ﹤0.01% | 1904 |
|
|
2017
Q3 | $228K | Buy |
3,332
+1,163
| +54% | +$62.1K | ﹤0.01% | 1908 |
|
|
2017
Q2 | $110K | Hold |
2,169
| – | – | ﹤0.01% | 2087 |
|
|
2017
Q1 | $87K | Hold |
2,169
| – | – | ﹤0.01% | 2153 |
|
|
2016
Q4 | $61K | Buy |
+2,169
| New | +$65.4K | ﹤0.01% | 2264 |
|
Other funds holding BPMC
IA
HNB
Canada Life's BPMC Position: Q3 2025 in Review
Canada Life sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 14,186 shares — an estimated $1.82M sold.
Canada Life first reported a position in BPMC in Q4 2016 and held it in 35 quarters. The position peaked at $1.82M in Q2 2025. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.
- Canada Life reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
- Canada Life sold 14,186 Blueprint Medicines shares in Q3 2025, an estimated $1.82M.
- Canada Life first reported a position in Blueprint Medicines in Q4 2016 and held it in 35 quarters.
- Canada Life's Blueprint Medicines position peaked at $1.82M in Q2 2025.
- 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.
Based on Canada Life's 13F filing for Q3 2025, filed 17 Nov 2025.